Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Peptidream Inc (4587 JP)
Watchlist
42
Analysis
Health Care
•
Japan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Softbank Corp
•
30 May 2022 19:24
JPX-Nikkei 400 Rebalance 2022: Leaderboard End-May 2022
A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-May 2022.
Janaghan Jeyakumar, CFA
Follow
525 Views
Share
bullish
•
Softbank Corp
•
28 Apr 2022 17:27
JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Apr 2022
A look at the potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-April 2022.
Janaghan Jeyakumar, CFA
Follow
587 Views
Share
bullish
•
Nippo Corp
•
30 Mar 2022 21:29
JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Mar 2022
A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-March 2022.
Janaghan Jeyakumar, CFA
Follow
527 Views
Share
bearish
•
Recruit Holdings
•
31 Jan 2022 17:49
JPX-Nikkei 400 Rebalance 2022: Leaderboard End-Jan 2022
A look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2022 based on trading data as of end-January 2022.
Janaghan Jeyakumar, CFA
Follow
503 Views
Share
bullish
•
SG Holdings
•
07 Aug 2021 11:41
JPX Nikkei 400 Index Rebalance: Big Turnover, Big Impact & A Market Consultation
There are 41 adds and 40 deletes for the JPX NK 400 Index. One-way turnover is high at 8.16% and will result in a trade of JPY 468bn. There will be...
Brian Freitas
Follow
662 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x